News | Radiation Oncology | April 27, 2023

Elekta’s latest Leksell Gamma Knife stereotactic radiosurgery (SRS) system, Esprit, wins Red Dot Award 

Elekta’s latest Leksell Gamma Knife stereotactic radiosurgery (SRS) system, Esprit, wins Red Dot Award

April 28, 2023 — Elekta Esprit, a high precision stereotactic radiosurgery device, used to treat targets in the brain, such as tumors, vascular malformations, or functional disorders, has been awarded the Red Dot Award for product design in the medical devices and technology design category. By combining form and function in an exquisite manner, Elekta Esprit has received an internationally renowned winner label of the highest reputation. 

According to the Red Dot organization, its award represents global recognition of belonging to the best in design and business and the Red Dot Design Award competition has been held since 1955. The jury, comprising some 50 international experts, tests, discusses and evaluates each entry individually. 

This latest incarnation of the trusted Leksell Gamma Knife offers more efficient and seamless workflows with a modern aesthetic and a clean, light and friendly expression. Moreover, Elekta Esprit emphasizes simple, minimalist design language that shifts the focus away from the machine and celebrates Elekta’s emphasis on the user and patient experience of the system. 

Susanna Francke Rodau, Senior VP & Head of Neuro Solutions, said: “The experience of the user and the patient is at the heart of this innovation, where design and function have been combined in a holistic, seamlessly integrated package. Although Esprit is technically complex, it is an easy-to-use solution capable of treating very challenging indications and provides life-changing results for patients.” 

Elekta Esprit offers more personalized and patient-friendly treatments, and a degree of precision able to protect the mind and the person. 

Elekta Esprit is CE marked and FDA 510(k) cleared, with limited global availability. 

For more information: www.elekta.com/elekta-esprit 


Related Content

News | Radiopharmaceuticals and Tracers

Dec. 11, 2025 — Telix Pharmaceuticals Ltd. has announced a strategic clinical collaboration with Varian, a Siemens ...

Time December 11, 2025
arrow
News | FDA

Dec. 02, 2025 — Alpha Tau Medical Ltd., the developer of the alpha-radiation cancer therapy Alpha DaRT, has announced ...

Time December 04, 2025
arrow
News | Interventional Radiology

Nov. 12, 2025 — On Nov. 11, Huntsman Cancer Institute at the University of Utah (the U) opened its first specialized ...

Time November 13, 2025
arrow
News | Radiology Business

Nov. 12, 2025 — Siemens has announced plans to deconsolidate its remaining stake in Siemens Healthineers (currently ...

Time November 13, 2025
arrow
News | Radiopharmaceuticals and Tracers

Nov. 11, 2025 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has released a position paper outlining ...

Time November 12, 2025
arrow
News | Prostate Cancer

Nov. 10, 2025 — Researchers at Wayne State University and the Barbara Ann Karmanos Cancer Institute have developed a ...

Time November 11, 2025
arrow
News | Lung Imaging

Nov. 3, 2025 — RevealDx, a leader in the characterization of lung nodules, has introduced MDR Certification of RevealAI ...

Time November 07, 2025
arrow
News | Artificial Intelligence

Nov. 6, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, recently announced that Volpara ...

Time November 07, 2025
arrow
News | Women's Health

Nov. 3, 2025 — —A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 ...

Time November 04, 2025
arrow
Feature | Kyle Hardner

Radiotherapy contributes to about 40% of all cancer cures but still lags behind systemic therapy in funding and ...

Time October 21, 2025
arrow
Subscribe Now